Given that several components of the Hippo pathway exert tumor-suppressive properties [26,27], and given that altered YAP/TAZ activity has been implicated in various diseases [29,34], therapeutic interventions designed to target this pathway hold significant promise for treating these diseases. This evidence concerns the gene TAFAZZIN and neoplasm.